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      Are pharmacists really “Playing Doctor” as a popular NBC show described the Mississippi 
Medicaid Pharmaceutical Care project?  No, but the bottom line of the NBC show was that 
pharmacists are changing their practice habits to compensate for the decreased rate of return on 
filling prescriptions. In reality, pharmacists are neither “playing” physician nor merely trying to 
pad their pockets with a newfound source of income.  While it is true that pharmacists are 
changing their practice habits, they are doing so for the betterment of their patients’ drug therapy 
outcomes and the healthcare system.  The pharmacist serves as the vital link between the patient, 
physician, and healthcare system.  By working with patients and physicians, pharmacists have 
demonstrated in the literature that they can improve patient drug therapy outcomes, thus 
preventing unnecessary healthcare expenditures (Fincham, 1998).  Pharmacists have long been 
held in highest esteem by patients, being voted the number one trusted professional for 10 
consecutive years.   The evidence is clear that pharmacists provide a valuable service to their 
patients and healthcare programs, thus they should be adequately compensated.  It is important 
for physicians, healthcare plans, and pharmacists to have a clear idea for what pharmacists are 
being compensated.  
 For what services should pharmacists be paid?  Cognitive reimbursement is a term used 
to describe payment for non-product-related services.  These services involve critical thought 
processes applied to the appropriateness of medications used by patients.  The term and practice 
has quickly evolved, as it is apparent that no one is going to pay pharmacists to simply think 
about patient care.  Payers and patients are ready to pay for what pharmacists can DO to improve 
patient outcomes.  The concept of Pharmacist Care or Pharmaceutical Care emerged to focus the 
pharmacist on all aspects of the delivery of care to patients.  Three major categories of 
reimbursed services are widely recognized: resolution of drug therapy problems, disease state or 
health management, and extensive patient self-management training and education.  Other areas 
where pharmacists have been successful billing for services are health promotion and disease 
prevention.  Table 1 illustrates the variety of health care areas in which services are provided by 
pharmacists around the country (Felkey, 1999). The payment for professional prescription filling 
ensures the safety of a product dispensed and OBRA90 or California mandated counseling.  The 
provision of pharmaceutical care services by a pharmacist is over and above any state or national 
requirements and warrants appropriate additional remuneration. 
The Healthcare Picture 
     In California, managed care is incorporated into virtually all health insurance plans.  The 
number of fee-for-service enrollees has steadily declined as a cost conscious society prepares for 
the next millennium. Under managed care, a health plan contracts with specific providers and 
pays them a capitated payment or a discounted fee-for-service amount.  Typically, providers are 
expected to assume some financial risk for high cost health care under risk sharing arrangements.  
Providers may also share some savings if the care provided is less costly than anticipated.  
Maintaining high quality health care is important to employers who, along with the government, 
are the major purchasers of health care in the U.S.  New National Committee on Quality 
Assurance (NCQA) measures compare various health plans on important aspects of the care 
provided.  Thus maintaining high quality care at the most cost-effective level is an important goal 
of managed care. 
     The number of patients paying the entire cost of prescriptions has also decreased as managed 
care plans grow.  Health plans covering prescription benefits increasingly use formularies and 
other utilization controls to maintain reasonable per member per month (PMPM) prescription 
costs.  Most prescription benefits are managed by pharmacy benefit managers (PBMs) in the 
form of separate companies or divisions within a health insurance company. 
Who are the Payers of Pharmaceutical Care Services? 
Value is at the core of determining who will pay for pharmacist care services.  For 
example, if pharmacists take part in an ACE inhibitor preferred product interchange program, an 
insurer may find this valuable and pay pharmacists for this activity.  On the other hand, patients 
may not find this service of particular value especially if the cost of the medication to the patient 
does not change.  Thus if a pharmacist were to ask a patient to pay for this service, it would likely 
be unsuccessful.  On the other hand, a travel medicine clinic that helps patients prepare for 
foreign travel on vacation or for business might be of value to patients, but of less interest to the 
health plan.   
Potential sources of reimbursement include patients and their families, insurance 
companies, medical groups, individual physicians, pharmacy benefit managers, manufacturers, 
employer groups, hospitals, home health care agencies, assisted living centers, and the 
government.  Patients are an important group because, as consumers, they are a driving force 
behind what services employers demand of insurers, the services insurers provide to stay 
competitive, and services the government will provide to the voting constituency. Table 2 lists 
some current and potential sources of payment for pharmacist services in California (please help 
us complete this table by faxing us your sources of payment in the survey at the end of this 
article). 
Methods of Payment and Setting Fees 
     Several mechanisms have been used to determine what to charge and how to pay for 
pharmacists’ services.  Some payment methods used to pay pharmacists and other healthcare 
providers include fee-for-service, per capita (capitated) payments, fees based on cost savings 
realized, and resource based relative-value scales (RBRVS).  Methods for payment of 
pharmacists are evolving.  As more is known about the costs and benefits of pharmaceutical care, 
the methods of payment will evolve as well.  As in the early days of paying physicians a fee-for-
service, this method is now the most common payment method in California for payment of 
pharmaceutical care services. Tempting as it may seem as a method for payment, fees based on 
cost savings realized may be severely reduced after initial year savings are squeezed out of the 
system.  It is likely that a combination of fee-for-service and capitated methods will emerge once 
pharmaceutical care is widely practiced. 
     Pharmacists use a variety of methods to determine how much to charge for a particular 
service.  Under the fee-for-service method, a flat rate is set for a particular service or fees are 
charged based on an hourly rate.  For example, some pharmacists charge $60/hour and then break 
the fee down into 10 minute increments depending on the length of the visit.  Others may charge 
a flat rate depending on the type of service and level of complexity.  For instance, a pharmacist 
might charge one fee (e.g. $100) for an initial asthma work-up and then a lower (e.g. $25) fee for 
each follow-up visit.  Mixing these two methods may continue to be a common practice.  The flat 
rate service fee works for standardized services such as disease state management and an hourly 
fee might work better for drug therapy problem resolution and services where time requirements 
are more variable.  An important factor in setting rates is the cost of providing the service.  The 
cost of the pharmacist’s time, space utilization, and other costs should be considered when 
setting fees.  Additionally, competition between pharmacists and from other providers will play 
an important role in what pharmacists charge.  The key to setting fees is to set them before 
marketing a service, in-service staff on the fee structure, and then let the patient know how much 
the care is going to cost before providing the service.  
     Non-distributive pharmacy services are not currently provided under a typical managed care 
capitated structure. As pharmacists continue to demonstrate the ability to effect positive patient 
outcomes, capitated methods to pay for pharmaceutical care may soon become reality.  A patient-
based capitated approach is used by some pharmacists to charge the patient or family a yearly fee 
that covers them regardless of number of times seen.  However, the inability to adjust fees 
midyear if a patient’s care becomes more labor intensive than originally estimated is a downside 
to the patient -based capitated program.   
     Finally, the most complicated system, but possibly the most accurate, is the resource-based 
relative value scale (RBRVS).  This pricing system is used by Medicare and some third party 
payers to pay for services by accounting for differences in the complexity of a patient visit.  In 
this complex system, relative value units are assigned to a service based on current procedural 
terminology (CPT) and other codes.  At this moment, not enough is known about the time 
requirements and benefits or the range of possible services provided by pharmacists to accurately 
determine a RBRVS for pharmacists providing care in the community pharmacy.  
     Some services provided by pharmacists will not be covered or paid by insurers.  Thus, the 
pharmacist must decide if patients will be billed for unreimbursed amounts.  Additionally, full 
payment could be collected from the patient and then the patient submits the claim to the insurer.  
Whichever method is chosen, the pharmacist should have a plan to charge patients for care the 
day the service begins and make it clear to the patient how the process will work prior to 
delivering services.  
Steps in Billing (see Figure 1) 
     Data Gathering-Once the pharmacy environment is ready for pharmaceutical care and a 
documentation method is in place, the pharmacist is ready to work with the patient and the 
patient’s physician. The information gathered during a patient interview or a patient-completed 
history form includes not only a medication history, but also a complete medical history.  The 
first step in the rather simple process of billing is to collect information from the patient 
regarding insurance plans.  This information can be obtained along with the complete medical 
history.  Both pharmacy benefits and medical benefits information should be obtained from the 
patient.  If the patient does have insurance, a statement that allows the pharmacist to accept 
assignment of benefits on the patient’s behalf for the services to be provided should be signed.  
The pharmacist could also include a statement obligating the patient to accept responsibility for 
any portion of the bill that the insurance company does not reimburse.  If the service provided is 
a disease management related service, and if the patient does not have medical insurance with a 
fee-for-service plan, the patient should be informed that they are responsible for the total amount 
of care provided.  If the patient has a managed care plan, the primary physician group may be 
responsible for all medical care services provided to the patient, including those disease 
management services provided by pharmacists.  In this case, the pharmacist should talk to the 
medical group about the value of the services provided.  If the pharmacist has identified a drug 
specific problem, such as non-compliance, the pharmacy benefit management company might 
provide payment.   
     Documentation-Documentation of patient care activities is vital to reimbursement. If you 
didn’t document it, you didn’t do it!  The type of documentation required for pharmaceutical care 
does not go on the back of a prescription, which makes it episodic and strictly drug related, nor 
can it simply be entered into many distribution-only systems.  Separate patient charts or a 
documentation computer system must be used to adequately track patient care.  By documenting 
patient care activities, a continuous record is created that allows each pharmacist to have an 
accurate and updated picture of the healthcare of every patient.  In addition, during a third party 
payer audit, evidence of the care provided should easily be retrievable.  To enhance the ability to 
gather and share information with other health care providers, the patient should sign a statement 
(usually at the end of the patient history form) allowing the release of medical information 
necessary for providing pharmaceutical care services and processing payment from a third party 
payer.  A drug therapy problem or healthcare need may arise from the data gathering stage or a 
previously identified one.  The resolution and follow-up of this patient care need or problem 
forms the basis of the billable event.   
     Medical Necessity-A medical necessity form serves several purposes and should be obtained 
before scheduled care is to be provided.  The first purpose is to inform the patient’s physician of 
the care the patient needs.  The second purpose is to inform the medical insurance company that 
the care provided is considered by the physician to be a necessary part of the patient’s medical 
care. Since the same diagnosis (ICD-9) codes that the physician uses for billing are used, the 
medical necessity form provides a place for the ICD-9 code and diagnosis to be entered by the 
physician or office staff.  Pharmacists must use the ICD-9 code assigned to that patient by the 
physician. It should not be left blank on the billing form or indirectly determined from the 
diagnosis.  If the physician signs and approves of the medical necessity, it may be prudent to call 
the medical insurance company for prior authorization. However, since pharmaceutical care is 
still a new concept to insurers, gaining prior authorization may be difficult.  The goals at this 
point are to determine what type of coverage the patient has, if the insurer covers referred 
specialists, the patient’s deductible and if its been met, and the process for submitting a claim (if 
you have not previously submitted a claim for this insurer).   Assuming prior authorization is 
obtained, the patient is ready to be seen.  Obtaining the medical necessity and prior authorization 
take time and are most appropriate for scheduled visits. 
     Billing Submission-At the completion of patient care, activities are documented and follow-up 
care is scheduled if necessary.  Contacting the payer to request prior authorization for a service 
may increase success in billing.  It is important to include in the dialogue with the payer that “the 
primary care physician has asked me [as a referred specialist] to instruct the patient on self-
monitoring of their disease”.  Currently there is no universally used on-line adjudication system 
for processing pharmaceutical care claims.  Thus promptly submitting forms for reimbursement 
after the patient encounter is important for the economic viability of the service.  If a disease 
management service has been provided, the medical necessity form should be sent along with the 
HCFA-1500 billing form to the medical insurer. The HCFA-1500 can be completed either 
manually or by using one of the commercially available computer programs (Poirier, 1999; 
Rudolph, 1997). It should be clear on this form that a pharmacist is providing the service because 
physician CPT codes are used.  Just like a dietician or podiatrist, the pharmacist is a referred 
specialist performing a service requested by the primary care physician. If the care provided is the 
resolution of a specific drug problem, for example compliance with a medication, some sources 
recommend using the National Community Pharmacists Association (NCPA) Pharmacist Care 
Claim form (Poirier, 1999; Rudolph, 1997).  This form collects specific data about the problem, 
action, result, time and specific drug(s) involved.  Whatever the form used and payer contacted, 
allow about one month for processing of claims before calling the third party payer about 
unresolved claims.  Patience and perseverance will be rewarded.   
Keys to Success 
     Billing for pharmaceutical care services requires different procedures, a patient focused 
environment, and the right mindset.  In traditional reimbursement, pharmacists are paid for 
dispensing a product.  This service is usually paid by the pharmacy benefits portion of the 
patient’s insurance coverage or by the patient directly.  In pharmaceutical care, the pharmacist is 
often billing the medical benefits provider rather than the pharmacy benefits provider for a 
service rather than a drug.  
     The provision of pharmaceutical care services requires all the pieces of the puzzle to be 
effective (Johnson, 1997): an appropriate patient care area, efficient workflow, effective use of 
ancillary personnel, written policy and procedures, training, documentation, a marketing and 
reimbursement strategy, and outcomes management.  Figure 2 describes some practical “do’s and 
don’ts” of reimbursement.  An important trap to avoid is the saying, “I’m not going to do it until 
I get paid for it” because payers have another saying, “we’re not going to pay you until you’re 
doing it”.  Providing pharmaceutical care is a result of the natural evolution of our profession and 
getting paid for that service is merely the next step. 
Figure 2 
Reimbursement Practice Points 
DOs 
 Start with a reasonable marketing plan and stick to it 
 Establish fees before you start a service 
 Provide a service that patients need and you enjoy doing 
 Make sure you can perform the service and do it well  
 Be very familiar with the procedures payers require for reimbursement 
 Verify medical coverage for your procedure and get authorization if possible  
 Be persistent and resubmit rejected claims! 
DON’Ts 
 Don’t send your patient care documentation forms in with your reimbursement forms 
 Don’t omit any boxes that need to be filled in on the HCFA-1500 form 
 Don’t bill the pharmacy benefits division of the third party payer for disease management 
services 
 
 Key terms used in this article or in billing 
 CPT (Common Procedural Terminology) 
 ICD-9 (International Classification of Diseases, 9th Revision) 
 UPIN (Universal Provider Identification Number) 
 RBRVS (Resource-based Relative Value Scale) 
 HCFA (Health Care Financing Administration) 
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 Table 1. Topic Areas of Pharmacist Services Where Reimbursement is Obtained Across the United States 
Addiction 
Administration                                                   
Allergy & Flu 
Alternative Medicine 
Anti-Coagulation 
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Table 2 
Pharmaceutical Care Reimbursement Projects in California for Community Pharmacists 
 
Disease Payer Comments 
Asthma Blue Cross of California high risk patients 
identified by payer and 
pharmacists paid $25 per 
visit up to 4 visits/year 
Pharmacist must be 
identified as a provider 
by taking approved 
coursework 
Diabetes and Asthma research project 
supports 
MediCal patients 
identified for a pilot 
project* 
Pharmacists paid for 
providing disease state 
management for high 
risk fee-for-service 
MediCal  patients in 7 
counties 
Pharmacist must be 
identified as a provider 
by meeting certain 
requirements 





Anticoagulation physician group pay percentage of 
pharmacist salary for 




asthma, and diabetes 
research project 





Pharmacist paid to 
manage identified high 
risk patients over 1 year 




County of Monterey 






Pharmacist paid a $10 
fee for approved 
submission of a 
prescription or drug 
therapy problem 
Diabetes CalOPTIMA adjudicated through 
PCN 
Pharmacist paid $5 fee 
for providing Diabetes 
Retinal Eye Exam 
Reminder  
Diabetes patient self pay, various 
health care plans on a 
patient specific need 
basis 
various pharmacists 
provide care and are 
paid for services by 
patients and health plans 
* proposed project-Contact Carlo Michelotti, CPhA for more information 
 
**proposed project-Contact Kathy Johnson, USC for more information 
  
Survey of Pharmacist Care Reimbursement in California 
 
Please take a moment to complete this survey.  We find there is a general lack of comprehensive information about 
what services are being paid for and by whom in California.  All information will be kept confidential.  Only 
compiled information, not individual responses will be published.  We will publish the summary results in a future 
issue of the Journal.  You may fax your results to Kathy Johnson, Pharm.D., Ph.D. (323) 442-1462 or via email:  
kjohnson@hsc.usc.edu     Thank you! 
 
 













4. How do you submit your claim for processing (eg paper claim using the HCFA-1500, NCPA Pharmacist Care 














7. Pharmacist Name, address, phone, fax  (in case we must clarify your responses) (this information will be kept  




Thank you for your input.  
FAX your information to:  Kathy Johnson 323-442-1462 
Mississippi Medicaid Project: 
 
The state of Mississippi has reacted to its extremely high fee for service emergency room costs by implementing a 
special pharmacist initiative.  The Health Care Financing Administration (HCFA) has granted a 2 ½ year waiver to 
compensate pharmacists for specific disease management services.  Four disease states have been selected for 
pharmacist management.  They include:  anticoagulation, asthma, dyslipidemia and diabetes.  Pharmacists must pass 
a disease specific credentialing exam, administered by the National Association of Boards of Pharmacy (NABP), and 
take hands on training from approved providers in order to receive payment for their services.  Pharmacists must also 
obtain physician referral, via a medical necessity form for each patient they feel is a candidate for their services.  A 
limited number of visits (10) are allowed per patient per year.  The fee paid per visit is $20.  An analysis of the 
impact of the project are due at the end of the demonstration period. 
